Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Clinical trial NCT07386158 · RECRUITING

Trial details

NCT number: NCT07386158
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vorolanib Clear Cell Renal Cell Carcinoma (ccRCC)Neoadjuvant Therapy

Start date: 2025-07-10
Primary completion: 2026-12-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.